Haverford Financial Services’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.46M | Sell |
51,458
-8,333
| -14% | -$798K | 1.33% | 29 |
|
|
2025
Q4 | $5.74M | Sell |
59,791
-301
| -0.5% | -$29.2K | 1.61% | 27 |
|
|
2025
Q3 | $5.72M | Sell |
60,092
-1,374
| -2% | -$126K | 1.61% | 26 |
|
|
2025
Q2 | $5.36M | Sell |
61,466
-138
| -0.2% | -$11.7K | 1.59% | 27 |
|
|
2025
Q1 | $5.54M | Sell |
61,604
-301
| -0.5% | -$26.9K | 1.71% | 28 |
|
|
2024
Q4 | $4.94M | Sell |
61,905
-31,301
| -34% | -$2.71M | 1.51% | 27 |
|
|
2024
Q3 | $8.39M | Sell |
93,206
-13,314
| -12% | -$1.12M | 2.4% | 20 |
|
|
2024
Q2 | $8.38M | Sell |
106,520
-12,133
| -10% | -$995K | 2.51% | 20 |
|
|
2024
Q1 | $10.3M | Sell |
118,653
-346
| -0.3% | -$29.5K | 2.98% | 17 |
|
|
2023
Q4 | $9.8M | Buy |
118,999
+205
| +0.2% | +$15.6K | 2.94% | 17 |
|
|
2023
Q3 | $9.31M | Sell |
118,794
-286
| -0.2% | -$23.9K | 3% | 18 |
|
|
2023
Q2 | $10.5M | Sell |
119,080
-490
| -0.4% | -$42.2K | 3.13% | 15 |
|
|
2023
Q1 | $9.64M | Buy |
119,570
+36,652
| +44% | +$2.99M | 3.01% | 16 |
|
|
2022
Q4 | $6.44M | Sell |
82,918
-26
| -0% | -$2.11K | 1.78% | 28 |
|
|
2022
Q3 | $6.7M | Sell |
82,944
-18
| -0% | -$1.62K | 2.05% | 22 |
|
|
2022
Q2 | $7.45M | Sell |
82,962
-2,528
| -3% | -$256K | 2.17% | 20 |
|
|
2022
Q1 | $9.48M | Buy |
85,490
+1,022
| +1% | +$108K | 2.34% | 17 |
|
|
2021
Q4 | $8.74M | Sell |
84,468
-1,683
| -2% | -$195K | 1.98% | 23 |
|
|
2021
Q3 | $10.8M | Sell |
86,151
-32
| -0% | -$4.14K | 2.63% | 16 |
|
|
2021
Q2 | $10.7M | Sell |
86,183
-20
| -0% | -$2.51K | 2.61% | 17 |
|
|
2021
Q1 | $10.2M | Sell |
86,203
-307
| -0.4% | -$36K | 2.66% | 17 |
|
|
2020
Q4 | $10.1M | Sell |
86,510
-50
| -0.1% | -$5.5K | 2.76% | 17 |
|
|
2020
Q3 | $8.99M | Buy |
86,560
+1,440
| +2% | +$145K | 2.77% | 15 |
|
|
2020
Q2 | $7.81M | Buy |
85,120
+30,941
| +57% | +$2.97M | 2.63% | 17 |
|
|
2020
Q1 | $4.89M | Buy |
54,179
+7,374
| +16% | +$784K | 1.97% | 21 |
|
|
2019
Q4 | $5.31M | Sell |
46,805
-1,690
| -3% | -$185K | 1.69% | 25 |
|
|
2019
Q3 | $5.27M | Sell |
48,495
-467
| -1% | -$48.7K | 1.79% | 24 |
|
|
2019
Q2 | $4.77M | Sell |
48,962
-228
| -0.5% | -$20.8K | 1.66% | 26 |
|
|
2019
Q1 | $4.48M | Buy |
49,190
+234
| +0.5% | +$20.9K | 1.61% | 28 |
|
|
2018
Q4 | $4.45M | Sell |
48,956
-54,268
| -53% | -$5.07M | 1.84% | 24 |
|
|
2018
Q3 | $10.2M | Sell |
103,224
-948
| -0.9% | -$87.6K | 3.6% | 10 |
|
|
2018
Q2 | $8.92M | Sell |
104,172
-772
| -0.7% | -$64.5K | 3.35% | 12 |
|
|
2018
Q1 | $8.42M | Sell |
104,944
-1,246
| -1% | -$103K | 3.2% | 11 |
|
|
2017
Q4 | $8.57M | Sell |
106,190
-464
| -0.4% | -$37.2K | 3.13% | 14 |
|
|
2017
Q3 | $8.29M | Sell |
106,654
-500
| -0.5% | -$41.5K | 3.24% | 13 |
|
|
2017
Q2 | $9.51M | Sell |
107,154
-340
| -0.3% | -$28.7K | 3.87% | 10 |
|
|
2017
Q1 | $8.66M | Sell |
107,494
-652
| -0.6% | -$50.9K | 3.57% | 14 |
|
|
2016
Q4 | $7.7M | Sell |
108,146
-1,283
| -1% | -$101K | 3.25% | 15 |
|
|
2016
Q3 | $9.46M | Sell |
109,429
-982
| -0.9% | -$85.6K | 4.07% | 10 |
|
|
2016
Q2 | $9.58M | Sell |
110,411
-1,629
| -1% | -$132K | 4.04% | 6 |
|
|
2016
Q1 | $8.4M | Sell |
112,040
-1,876
| -2% | -$141K | 3.54% | 13 |
|
|
2015
Q4 | $8.76M | Buy |
113,916
+12,428
| +12% | +$936K | 3.74% | 10 |
|
|
2015
Q3 | $6.79M | Buy |
101,488
+42,875
| +73% | +$3.16M | 3.14% | 17 |
|
|
2015
Q2 | $4.34M | Sell |
58,613
-2,873
| -5% | -$220K | 1.84% | 29 |
|
|
2015
Q1 | $4.8M | Buy |
+61,486
| New | +$4.66M | 1.95% | 28 |
|
Other funds holding MDT
VCM
VPM
Haverford Financial Services's MDT Position: Q1 2026 in Review
Haverford Financial Services reduced its Medtronic (MDT) stake by 14% in Q1 2026, selling an estimated $798K and leaving 51,458 shares worth $4.46M. The position accounts for 1.33% of the portfolio, ranked #29.
Haverford Financial Services first reported a position in MDT in Q1 2015 and has held it in 45 quarters since. The position peaked at $10.8M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Haverford Financial Services held 51,458 shares of Medtronic worth $4.46M as of Q1 2026.
- Haverford Financial Services sold 8,333 Medtronic shares in Q1 2026, an estimated $798K.
- Medtronic made up 1.33% of Haverford Financial Services's portfolio in Q1 2026, its #29 holding.
- Haverford Financial Services first reported a position in Medtronic in Q1 2015 and has held it in 45 quarters since.
- Haverford Financial Services's Medtronic position peaked at $10.8M in Q3 2021.
- 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Haverford Financial Services's 13F filing for Q1 2026, filed 11 May 2026.